Agreement Reached for Joint Development of New TB Vaccines
Monday, November 11, 2013
A basic agreement has been reached among NIBIO, Aeras and Create Vaccine for joint development of new TB vaccines based on the human parainfluenza type-2 vector technology.
The three parties intend to enter into a formal joint development agreement by the end of December this year. Create Vaccine is a joint venture company established on
Tuberculosis is one of the world’s Big Three infectious diseases. Some 8.6 million people around the world become infected every year, while some 1.3 million patients are fatally victimized. It is widespread, particularly in
- Health Care